Jae-Hyun Hong
Directeur Général chez SINIL PHARMACEUTICAL CO., LTD.
Fortune : 12 M $ au 30/04/2024
Profil
Jae-Hyun Hong is currently the President, Chief Executive Officer & Director at SINIL PHARMACEUTICAL Co., Ltd.
She is also an Investment Manager at DSC Investment, Inc. (Venture Capital).
Ms. Hong holds an MBA from Korea University and an undergraduate degree from Dongduk Women's University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/12/2023 | 2 406 364 ( 20,08% ) | 12 M $ | 30/04/2024 |
Postes actifs de Jae-Hyun Hong
| Sociétés | Poste | Début |
|---|---|---|
| SINIL PHARMACEUTICAL CO., LTD. | Directeur Général | 01/01/2000 |
DSC Investment, Inc. (Venture Capital)
 DSC Investment, Inc. (Venture Capital) Investment ManagersFinance DSC Investment, Inc. (Venture Capital) (DSC Investment) is the operating venture capital division of DSC Investment, Inc. The firm was founded in 2012 and is headquartered in Seoul, South Korea. | Private Equity Investor | - |
Formation de Jae-Hyun Hong
| Dongduk Women's University | Undergraduate Degree |
| Korea University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SINIL PHARMACEUTICAL CO., LTD. | Health Technology |
| Entreprise privées | 1 |
|---|---|
DSC Investment, Inc. (Venture Capital)
DSC Investment, Inc. (Venture Capital) Investment ManagersFinance DSC Investment, Inc. (Venture Capital) (DSC Investment) is the operating venture capital division of DSC Investment, Inc. The firm was founded in 2012 and is headquartered in Seoul, South Korea. | Finance |
